Showing results (1441-1450 of 2,107) with videos related to
Sort By:
Pageof 211
CNS Drugs|November 21, 2018
Impact of Antidepressant Use on the Trajectory of Alzheimer's Disease: Evidence, Mechanisms, and Therapeutic ImplicationsRita Khoury, George T GrossbergCNS Drugs|March 18, 2017
Pharmacotherapy in Generalized Anxiety Disorder: Novel Experimental Medicine Models and Emerging Drug TargetsDavid S Baldwin, Ruihua Hou, Robert Gordon, et al.CNS Drugs|April 6, 2017
Adherence and Persistence Across Antidepressant Therapeutic Classes: A Retrospective Claims Analysis Among Insured US Patients with Major Depressive Disorder (MDD)Katelyn R Keyloun, Ryan N Hansen, Zsolt Hepp, et al.CNS Drugs|March 25, 2017
Newer Antiepileptic Drugs in Status Epilepticus: Prescription Trends and Outcomes in Comparison with Traditional AgentsIsabelle Beuchat, Jan Novy, Andrea O RossettiCNS Drugs|March 5, 2019
Risk of Acute Liver Injury in Agomelatine and Other Antidepressant Users in Four European Countries: A Cohort and Nested Case-Control Study Using Automated Health Data SourcesManel Pladevall-Vila, Anton Pottegård, Tania Schink, et al.CNS Drugs|March 5, 2019
A Close Look at BACE1 Inhibitors for Alzheimer's Disease TreatmentBrati Das, Riqiang YanCNS Drugs|April 6, 2019
The Effect of Non-Gabapentinoid Anticonvulsants on Sensorimotor Recovery After Human Spinal Cord InjuryFreda M Warner, Catherine R Jutzeler, Jacquelyn J Cragg, et al.CNS Drugs|July 18, 2019
Branched-Chain Amino Acids and Seizures: A Systematic Review of the LiteratureShaun E Gruenbaum, Eric C Chen, Mani Ratnesh Singh Sandhu, et al.CNS Drugs|January 20, 2017
Diazepam in the Treatment of Moderate to Severe Alcohol WithdrawalSteven J WeintraubCNS Drugs|January 21, 2017
Nogo-A Antibodies for Progressive Multiple SclerosisBenjamin V Ineichen, Patricia S Plattner, Nicolas Good, et al.Pageof 211